Covered recipient · General Payments record
GARY GIBSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$2,605.68
- Reported across 163 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $599.82 | 33 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $145.30 | 9 |
| PFIZER INC. | $114.56 | 5 |
| Corcept Therapeutics | $60.86 | 3 |
| Lilly USA, LLC | $58.79 | 4 |
| Averitas Pharma Inc. | $54.83 | 2 |
| Amgen Inc. | $52.31 | 3 |
| Acerta Pharma LLC | $47.99 | 3 |
| Exact Sciences Corporation | $17.23 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.80 | 1 |
| Medtronic, Inc. | $15.67 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.69 | 02/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201922452 | CMS |
| ABBVIE INC. | $21.66 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201922454 | CMS |
| ABBVIE INC. | $20.26 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201922456 | CMS |
| ABBVIE INC. | $18.13 | 05/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201922458 | CMS |
| ABBVIE INC. | $7.33 | 08/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201922460 | CMS |
| ABBVIE INC. | $22.72 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201922462 | CMS |
| ABBVIE INC. | $17.53 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201922464 | CMS |
| ABBVIE INC. | $22.47 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201922466 | CMS |
| ABBVIE INC. | $7.51 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201922468 | CMS |
| Amgen Inc. | $15.91 | 01/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228502825 | CMS |
| Amgen Inc. | $17.15 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228502827 | CMS |
| Amgen Inc. | $19.25 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228502829 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.43 | 03/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206901675 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.06 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207121418 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.50 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207005025 | CMS |
| Averitas Pharma Inc. | $19.91 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248548181 | CMS |
| Averitas Pharma Inc. | $34.92 | 09/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248548183 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.48 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225550246 | CMS |
| Corcept Therapeutics | $19.32 | 01/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214226335 | CMS |
| Corcept Therapeutics | $19.86 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214226357 | CMS |
| Corcept Therapeutics | $21.68 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214226429 | CMS |
| Exact Sciences Corporation | $17.23 | 06/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235276857 | CMS |
| Lilly USA, LLC | $15.72 | 02/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186638213 | CMS |
| Lilly USA, LLC | $13.62 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186568004 | CMS |
| Lilly USA, LLC | $14.75 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186653143 | CMS |
| Lilly USA, LLC | $14.70 | 09/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186653145 | CMS |
| Medtronic, Inc. | $15.67 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218853632 | CMS |
| PFIZER INC. | $25.67 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229116878 | CMS |
| PFIZER INC. | $19.94 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229195295 | CMS |
| PFIZER INC. | $20.16 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229188324 | CMS |
| PFIZER INC. | $27.42 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229294230 | CMS |
| PFIZER INC. | $21.37 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230712830 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.80 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223831438 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.